Volume 47, Issue 4 pp. 915-920
Full Access

Intracranial Self-Stimulation and Locomotor Traces as Indicators for Evaluating the Homopantothenic Acid

Morikuni Takigawa M.D.

Corresponding Author

Morikuni Takigawa M.D.

Health Service Center, Kagoshima University, Kagoshima

Morikuni Takigawa, M.D., Department of Health Service Center, Kagoshima University, 1–21-24 Koorimoto, Kagoshima 890, Japan.Search for more papers by this author
Kenichi Ueyama M.D.

Kenichi Ueyama M.D.

*Department of Neuropsychiatry, Faculty of Medicine, Kagoshima University, Kagoshima

Search for more papers by this author
Hiroshi Fukuzako M.D.

Hiroshi Fukuzako M.D.

*Department of Neuropsychiatry, Faculty of Medicine, Kagoshima University, Kagoshima

Search for more papers by this author
Hirohisa Maeda M.D.

Hirohisa Maeda M.D.

*Department of Neuropsychiatry, Faculty of Medicine, Kagoshima University, Kagoshima

Search for more papers by this author
Kei Matsumoto M.D.

Kei Matsumoto M.D.

*Department of Neuropsychiatry, Faculty of Medicine, Kagoshima University, Kagoshima

Search for more papers by this author

Abstract

Abstract: Our paper compares the effect of homopantothenic acid (HOPA) and haloperidol (HAL), i.e., representative neuroleptics, on intracranial self-stimulation (ICSS) and locomotor activity. These experiments showed that HOPA inhibited abnormal hyperactivity induced by methamphetamine (MAP) but did not inhibit ICSS which is considered with respect to physiological motivations. On the other hand, haloperidol (HAL) markedly inhibited both ICSS and abnormal hyperactivity induced by MAP. We propose that combined ICSS and locomotor traces can be chosen as indicators for evaluation and developing the new neuroleptics.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.